Melanoma in pregnancy – where we are?

Dariusz Izycki; Christopher Patrick Kerrigan; Maciej Kazmierczak

doi:10.5114/pm.2013.39806

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

6/2013
vol. 12

Send email

Copy url:

abstract:

Review paper

Melanoma in pregnancy – where we are?

Dariusz Izycki

,

Christopher Patrick Kerrigan

,

Maciej Kazmierczak

Przegląd Menopauzalny 2013; 17 (6): 493-495

DOI: https://doi.org/10.5114/pm.2013.39806

Online publish date: 2013/12/30

View full text Get citation

PlumX metrics:

With rising rates of melanoma and women bearing children at older ages, the incidence of malignant melanoma in pregnancy will continue to increase. Initial reports in the 1950s portrayed a belief of the medical community that pregnant women who were diagnosed with malignant melanoma suffered a poorer prognosis. Numerous studies since then have shown that this is not the case, and pregnancy has not been shown to have a negative impact on the prognosis of malignant melanoma. Various mechanisms of hormones affecting malignant melanoma have been proposed, although nothing conclusive has been found. And although very rare, fetal metastasis is a serious risk and needs to be kept under consideration. Continual research and period reviews are necessary to best understand any effects of pregnancy on malignant melanoma, guide research, and maximize patient care.

keywords:

Melanoma in pregnancy – where we are?

Dariusz Izycki , Christopher Patrick Kerrigan , Maciej Kazmierczak

melanoma malignum, pregnancy

Dariusz Izycki

,

Christopher Patrick Kerrigan

,

Maciej Kazmierczak